top of page

26 Jan 2027 (Available)

Apply by: 19 Jan 2027

Semester B. All dates are provisional and may be subject to change

26 Jan 2027 (Online), 02 Feb 2027 (On Campus), 03 Feb 2027 (On Campus), 11 May 2027 (In-class safety assessment - On Campus), 12 May 2027 (On Campus), 08 Jun 2027 (Assessment Online), 09 Jun 2027 (Assessment Online), 29 Jun 2027 (Portfolio of Injections Submitted Online)

Course overview

THIS PAGE IS CURRENTLY BEING UPDATED FOR 2026/27. APPLICATIONS ARE NOT YET OPEN.


Course description/details

This module is for experienced physiotherapists who wish to include injection therapy as a part of their holistic management of patients with musculoskeletal dysfunction involving the peripheral joints. The module will include lectures, tutorials, workshops and practical sessions for students to develop the knowledge, understanding and skills to be able to perform injection therapy safely, effectively and competently. Learning will be underpinned by a critical appreciation of the current evidence base within this field of practice and is adheres to current Chartered Society of Physiotherapy Expectations of Educational Programmes for Injection Therapy (CSP, 2026).


Course content

Topics will include review of anatomy and relevant musculoskeletal pathologies that may be suitable for injection therapy, pharmacological, ethical and medico-legal considerations, clinical reasoning and advanced musculoskeletal assessment procedures including palpation of soft tissues. Content also includes the practical application of injection therapy including indications, contraindications, precautions, possible side-effects and identification and management of adverse events. The documentation of injection therapy procedures including evaluation of outcome will be highlighted. The development/enhancement of communication skills with the patient/client and the wider health professional team will be emphasised. Students will be expected to undertake a log of their learning in practice environment and reflect on their own performance. A minimum of 10 supervised injections must be successfully completed in the workplace and be signed off by a mentor.


Course Notes

This module is equivalent to 150 hours of student effort including 5 taught days and takes place online (day 1) and at College Lane Campus, Hatfield (days 2-5).

All applications are considered on a first come, first served basis. Once the module is full the application portal will close, so early application is advised. 


Course dates (All dates are provisional and may be subject to change)

Day 1 - Tuesday 26th January 2027, 9am-5pm (Online)

Day 2 - Tuesday 2nd February 2027, 9am-5pm (On campus)

Day 3 - Wednesday 3rd February 2027, 9am-5pm (On campus)

Day 4 - Tuesday 11th May 2027, 9am-5pm (On campus)

Day 5 - Wednesday 12th May 2027, 9am-5pm (On campus)


Assessment

Tuesday 11th May 2027 - In-class safety assessment - Day 4

Tuesday 8th June and Wednesday 9th June 2027 - Coursework (online presentation and professional discussion, submission of presentation online: Tuesday 1st May 2027)

Tuesday 29th June 2027 - Portfolio of Injections undertaken in practice (submitted online)


Assessment details

Case presentation on a relevant musculoskeletal patient that the student has injected in practice followed by a professional discussion. The assessment will normally be synchronous and online.

Examination (Pass/Fail):

In-class safety assessment.

Practical (Pass/Fail):

Portfolio of ten injections in practice (pass/fail)

All elements must be passed; there is no compensation between assessments.

Learning Outcomes

On successful completion of this module students will be able to:


Knowledge and understanding:

KU1: Critically discuss and synthesise the current evidence base to evaluate the anatomical structures and peripheral musculoskeletal pathologies that may be suitable for injection therapy.

KU2: Demonstrate in-depth knowledge and understanding of the pharmacology of the medicines used in musculoskeletal injection-therapy including the indications, contraindications possible side-effects and adverse reactions that may occur and discuss the management of any adverse event.  

KU3: Demonstrate in-depth knowledge and understanding of the regulation and control of medicines in relation to musculoskeletal injection therapy.


Intellectual, practical and transferable skills:

IPT1: Demonstrate advanced musculoskeletal assessment skills within a clinical reasoning framework to identify and select appropriate structures for injection therapy.

IPT2: Perform musculoskeletal injection procedures accurately, safely and competently, demonstrating clinical proficiency in the appropriate delivery of a range of injection therapy techniques used within the holistic management of musculoskeletal conditions.

IPT3: Document and critically evaluate the outcome and management of injection therapy procedures, communicating effectively and confidently with patients and others and reflect on their own performance.


Who teaches the course

The course is normally facilitated by Matthew Guilliatt, Module Lead and Advanced Clinical Practitioner in Musculoskeletal Physiotherapy. Regular contributors include: Kelly Lefteri (Principal Lecturer/Pharmacist), Rishi Navsaria (Senior Lecturer/Consultant Physiotherapist) & Gulten Dogan (Senior Lecturer/Advanced Physiotherapy Practitioner) and other experts from clinical practice and research.


What our students say

“Very good and delivered appropriately, lots of time for practice and questions” 

“Great support and a relaxed environment. Good for learning” 

“Excellent tutors” 

“Very clear instructions” 

“Very good few days, I enjoyed immensely” 

“Very informative and adaptable to the needs of the group” 

“Very specific and all common joints were included” 







This module can contribute to the following programme(s)

HMAPHYMSC: MSc Advanced Physiotherapy

Accredited by

Funding

£1,545.00

The price quoted above is for a 15 credit module in the 2026/27 academic year and applies to students who are assessed as Home fee payers ONLY. Fees will differ for students assessed as Overseas fee payers. Fee assessment decisions follow UKCISA (UK Council for International Student Affairs) guidance, which is based on UK law and government regulations. Further information on who will pay Home or Overseas tuition fees can be found here: https://ask.herts.ac.uk/will-i-pay-home-or-international-tuition-fees

Once confirmed, a student’s fee status will normally remain the same for the duration of their course. However, information regarding fee reassessment is available here: https://ask.herts.ac.uk/will-i-pay-home-or-international-tuition-fees#FeeReassessment  

Eligible students may be able to apply for a Postgraduate Student Loan. Please note that to access this funding, you must enrol on the full MSc programme; funding is not available for individual modules or interim awards (for example, a Postgraduate Diploma). Further information is available at: https://www.gov.uk/masters-loan

Further details, including tuition fee amounts, fee policy and payment deadlines, can be found here: https://www.herts.ac.uk/study/fees-and-funding/fee-information/fees-and-finance-policy-documents

If you require further information or have any questions regarding fees, please contact: cpdhealth@herts.ac.uk

Why Choose HERTS?

Excellent sector connections: we have extensive links with eight NHS Trusts and Local Authorities in Hertfordshire.

Links with over 98 NHS Trusts and Local Authorities in East Anglia and London regions.

Flexibility: we provide flexible study options to ensure you can fit CPD study around your busy professional and personal lives.

Location: the main University of Hertfordshire campus is 25 minutes from London with easy access by both road and rail services.

NMC_216.png
business3.jpg
GraphicHighlight_bottom.png

Course details

Course leader

Administrator

Julie Porter

Telephone

01707 284800

Course delivery

Blended. Number of Learner Hours: Scheduled 40; Independent 60; Placement/work based 50

Downloads

Prerequisites

All applicants must:

  • Be a qualified Physiotherapist with BSc (Hons) in Physiotherapy or equivalent physiotherapy qualification.
  • Have current HCPC Registration.
  • Be able to evidence current appropriate indemnity insurance for practice - Chartered Society of Physiotherapy PLI (Public Liability Insurance). CSP certificates can be located on the CSP Website, once you log-in at:  https://www.csp.org.uk/evidence-professional-liability-insurance
  • Provide a signed /dated letter of evidence of appropriate Hepatitis B immunisation from applicants employing Occupational Health Department or General Practitioner (using mandatory UH template provided; note we do not accept immunisation records)
  • Provide a signed/dated letter from a qualified practitioner who has agreed to prescribe the necessary drugs for injection therapy (using mandatory UH template provided)
  • Provide a signed/dated letter from a suitably qualified mentor who will supervise and examine injection therapy in the workplace (using mandatory UH template provided).
  • Provide a signed/dated letter from their employer confirming support for attendance on the module and access to relevant clinical cases to achieve the practical experience of injection with support from their mentor (using mandatory UH template provided).
  • Provide evidence of contemporaneous adult basic life support training (level 2 accepted only).
  • Be currently practising in a country where injection-therapy is recognised as being within the scope of practice of physiotherapy in that country.
  • Evidence of at least one year’s post-qualification experience in a musculoskeletal physiotherapy setting.
2536repro_2200.jpg
GraphicHighlight_top2.png

Tell me more about this course

Make an enquiry

3407-383-Medicine-Surgery_edited_edited.jpg
GraphicHighlight_top2.png
GraphicHighlight_top.jpg

School of Health, Medicine and Life Sciences

7HSK2230 [Module] 2026/27 - £1,545.00

Musculoskeletal Injection Therapy

15 Credits

Academic Level: 7

bottom of page